The Filing Desk

GeoVax Labs vs Cartesian Therapeutics

GeoVax Labs GOVX · Cartesian Therapeutics RNAC · Pharmaceuticals

Cartesian Therapeutics reported revenue of $3 million in fiscal 2025, about the same as GeoVax Labs' $2 million in fiscal 2025. GeoVax Labs' revenue fell 37.1% in its latest year, and Cartesian Therapeutics' fell 92.8%. GeoVax Labs had an operating margin of -869.3%, against -5127.1% at Cartesian Therapeutics. Free cash flow was −$22 million at GeoVax Labs and −$79 million at Cartesian Therapeutics.

Side by side

GeoVax LabsCartesian Therapeutics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$2M$3M
Revenue growth−37.1%−92.8%
Revenue growth a year, last 5 years6.8%−29.9%
Gross margin——
Operating margin−869.3%−5,127.1%
Net margin−862.3%−4,658.6%
Free cash flow−$22M−$79M
Free cash flow margin−863.8%−2,838.6%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count361.9%49.6%
Last close$1.91$5.89
P/E at the last close——
Insider trades, last 12 months—bought $205,800, sold $258,683
Piotroski F-score2 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
GeoVax LabsCartesian Therapeutics
Operating margin
Percent of revenue
GeoVax LabsCartesian Therapeutics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
GeoVax LabsCartesian Therapeutics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the GeoVax Labs and Cartesian Therapeutics pages.